AB0616 Cost analysis related to subcutaneous immunoglobulins in patients with inflammatory myopathies and immune-mediated chronic neuropathies. results of an open label study
AB0616 Cost analysis related to subcutaneous immunoglobulins in patients with inflammatory myopathies and immune-mediated chronic neuropathies. results of an open label study